首页> 美国卫生研究院文献>Oncotarget >Tumor promoter-induced cellular senescence: cell cycle arrest followed by geroconversion
【2h】

Tumor promoter-induced cellular senescence: cell cycle arrest followed by geroconversion

机译:肿瘤启动子诱导的细胞衰老:细胞周期停滞继而发生转态

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Phorbol ester (PMA or TPA), a tumor promoter, can cause either proliferation or cell cycle arrest, depending on cellular context. For example, in SKBr3 breast cancer cells, PMA hyper-activates the MEK/MAPK pathway, thus inducing p21 and cell cycle arrest. Here we showed that PMA-induced arrest was followed by conversion to cellular senescence (geroconversion). Geroconversion was associated with active mTOR and S6 kinase (S6K). Rapamycin suppressed geroconversion, maintaining quiescence instead. In this model, PMA induced arrest (step one of a senescence program), whereas constitutively active mTOR drove geroconversion (step two). Without affecting Akt phosphorylation, PMA increased phosphorylation of S6K (T389) and S6 (S240/244), and that was completely prevented by rapamycin. Yet, T421/S424 and S235/236 (p-S6K and p-S6, respectively) phosphorylation became rapamycin-insensitive in the presence of PMA. Either MEK or mTOR was sufficient to phosphorylate these PMA-induced rapamycin-resistant sites because co-treatment with U0126 and rapamycin was required to abrogate them. We next tested whether activation of rapamycin-insensitive pathways would shift quiescence towards senescence. In HT-p21 cells, cell cycle arrest was caused by IPTG-inducible p21 and was spontaneously followed by mTOR-dependent geroconversion. Rapamycin suppressed geroconversion, whereas PMA partially counteracted the effect of rapamycin, revealing the involvement of rapamycin-insensitive gerogenic pathways. In normal RPE cells arrested by serum withdrawal, the mTOR/pS6 pathway was inhibited and cells remained quiescent. PMA transiently activated mTOR, enabling partial geroconversion. We conclude that PMA can initiate a senescent program by either inducing arrest or fostering geroconversion or both. Rapamycin can decrease gero-conversion by PMA, without preventing PMA-induced arrest. The tumor promoter PMA is a gero-promoter, which may be useful to study aging in mammals.
机译:取决于人体环境,肿瘤启动子磷酸酯(PMA或TPA)可引起增殖或细胞周期停滞。例如,在SKBr3乳腺癌细胞中,PMA过度激活MEK / MAPK途径,从而诱导p21和细胞周期停滞。在这里,我们显示了PMA诱导的阻滞,然后转化为细胞衰老(基因转化)。 Geroconversion与活跃的mTOR和S6激酶(S6K)相关。雷帕霉素抑制了转基因,而保持了静止。在该模型中,PMA诱导了阻滞(衰老程序的第一步),而组成型活性mTOR导致了转气(第二步)。在不影响Akt磷酸化的情况下,PMA增强了S6K(T389)和S6(S240 / 244)的磷酸化,雷帕霉素可完全防止这种磷酸化。然而,在PMA存在下,T421 / S424和S235 / 236(分别为p-S6K和p-S6)的磷酸化对雷帕霉素不敏感。 MEK或mTOR都足以磷酸化这些PMA诱导的雷帕霉素抗性位点,因为需要用U0126和雷帕霉素共同处理才能消除它们。接下来,我们测试了雷帕霉素不敏感途径的激活是否会使静止期向衰老转变。在HT-p21细胞中,细胞周期停滞是由IPTG诱导的p21引起的,然后自然而然地发生了mTOR依赖性的转基因。雷帕霉素抑制了转基因,而PMA部分抵消了雷帕霉素的作用,从而揭示了雷帕霉素不敏感的生殖途径的参与。在正常的RPE细胞中,由于血清停药而停滞,mTOR / pS6途径被抑制,细胞保持静止。 PMA瞬时激活了mTOR,从而实现了部分Geroconversion。我们得出的结论是,PMA可以通过诱发逮捕或促进老年性转换或两者同时启动衰老程序。雷帕霉素可以减少PMA引起的转阴,而不会阻止PMA引起的停搏。肿瘤启动子PMA是一种启动子,可用于研究哺乳动物的衰老。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号